-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q3 2024.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $0.000.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Financing Activities for the twelve months ending September 30, 2024 was -$1.69B, a 17.4% increase year-over-year.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.91B, a 28.6% decline from 2022.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.49B, a 31.5% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$2.17B, a 15.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)